USADA announced today that Michael Meacham, of Pennsburg, Pa., an athlete in the sport of triathlon, has accepted a one-year sanction after an anti-doping rule violation. Meacham, 42, tested positive for methenolone and its metabolites, as well as exogenous boldenone, following an out-of-competition urine sample he provided on August 19, 2017.

His urine sample confirmed positive for exogenous boldenone by analysis using a specialized test that differentiates between anabolic-androgenic steroids naturally produced by the body and prohibited anabolic agents of external origin. The use of anabolic agents is prohibited at all times under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic Committee National Anti-Doping Policies, and the International Triathlon Union Anti-Doping Rules, all of which have adopted the World Anti-Doping Code and the WADA Prohibited List.

During USADA’s investigation into the circumstances of the case, Meacham also admitted that, beginning in November 2013, he had periodically used additional prohibited substances. But because of the substantial assistance provided that led to the discovery and bringing forward of a criminal offense, Meacham’s one-year period of ineligibility was reduced from four years.

Meacham’s one-year period of ineligibility began on August 19, 2017, the date his positive sample was collected. In addition, Meacham has been disqualified from all competitive results obtained on and subsequent to November 1, 2013, including forfeiture of any medals, points and prizes.

• This media release was published by the US Anti-Doping Agency (USADA) on 29 June 2018. Click here for the original.